Treatment of familial hypercholesterolemia with a combination of bezafibrate and guar-Reference-Cited by-同舟云学术

Treatment of familial hypercholesterolemia with a combination of bezafibrate and guar

Published:1982-12 Issue:3 Volume:45 Page:291-297
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Wirth A.,Middelhoff G.,Braeuning Ch.,Schlierf G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Medikamentöse Behandlung primärer Hyperlipoproteinämien;Klose;Klin. Wschr.,1978

2. Type II-Hyperlipoproteinemia;Myant,1976

3. Metabolic Effects of Nicotinic Acid and its Derivatives;Gey,1971

4. Interruption of the enterohepatic circulation of bile acids in man — Comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism;Grundy;J. Lab. Clin. Med.,1978

5. Langzeitbehandlung primärer Hyperlipidämien mit Clofibrat;Schlierf;Fortschr. Med.,1970

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?;Current Opinion in Lipidology;2023-11-01

2. The effects of guar gum supplementation on lipid profile in adults: a GRADE-assessed systematic review, meta-regression and dose–response meta-analysis of randomised placebo-controlled trials;British Journal of Nutrition;2022-07-15

3. Advances in familial hypercholesterolaemia in children;The Lancet Child & Adolescent Health;2021-09

4. Impact of Diet on Plasma Lipids in Individuals with Heterozygous Familial Hypercholesterolemia: A Systematic Review of Randomized Controlled Nutritional Studies;Nutrients;2021-01-15

5. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis;Nutrients;2020-08-13